This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Puvvada Sri Ramchandra Murthy: Innovator in Pharmaceutical Sciences
Introduction
Puvvada Sri Ramchandra Murthy is a notable inventor based in Lucknow, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel drug formulations. His work focuses on improving the efficacy and safety of opioid peptides, which are crucial in pain management.
Latest Patents
Puvvada Sri Ramchandra Murthy holds a patent for "Inclusion complexes of a high potent opioid peptide, pharmaceutical compositions and method of treatment." This invention provides novel inclusion complexes of the highly potent opioid peptide L-Tyrosyl-D-alanyl-glycyl-N-methylphenylalanyl-glycyl-isopropylamide with cyclodextrin. The pharmaceutical preparations containing these inclusion complexes demonstrate improved solubility in water and enhanced biopharmaceutical properties, such as reduced toxicity, better analgesic action, and non-addiction properties. He has 1 patent to his name.
Career Highlights
Puvvada Sri Ramchandra Murthy is associated with the Council of Scientific and Industrial Research, where he conducts research aimed at advancing pharmaceutical technologies. His innovative approach has led to significant advancements in drug formulation and delivery systems.
Collaborations
He has collaborated with notable colleagues, including Anil Kumar Dwivedi and Madhu Khanna, to further enhance the impact of his research in the pharmaceutical field.
Conclusion
Puvvada Sri Ramchandra Murthy's contributions to pharmaceutical sciences exemplify the importance of innovation in improving drug safety and efficacy. His work continues to influence the development of better therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
